Showing 71 - 80 of 336,187
effects. Standard anti-trust analysis of mergers, in pharmaceuticals as in other industries, focuses on the proposed merger … in the US, because the US healthcare system relies primarily on market forces rather than regulation to assure consumer …
Persistent link: https://www.econbiz.de/10013219540
Pharmaceutical markets are complex. Multiple agents, including doctors, insurers, and pharmacies, play critical roles that affect competition between manufacturers and patient choice between drugs. This complexity, however, is neglected in standard antitrust analysis. In evaluating proposed...
Persistent link: https://www.econbiz.de/10013241397
Persistent link: https://www.econbiz.de/10014110600
One of the most difficult legal issues today involves settlements by which brand-name drug companies pay generic firms to delay entering the market. Such conduct requires courts to consider not only patent and antitrust law, but also the Hatch-Waxman Act, the complex regime governing behavior in...
Persistent link: https://www.econbiz.de/10013100789
Persistent link: https://www.econbiz.de/10012970248
A lot changed between 2008 and 2015. Lindsay McSweeney's stewardship cemented the importance of CPI Antitrust Chronicle. Standard-essential patents, the smartphone patent wars, and patent trolls thrust themselves onto the IP/antitrust scene. But perhaps the most significant change is the...
Persistent link: https://www.econbiz.de/10013010245
The Supreme Court's decision in FTC v. Actavis has justly received widespread attention for its antitrust analysis of settlements by which brand-name drug companies pay generics to delay entering the market. Much of the attention has focused on the application of the Court's standard and the...
Persistent link: https://www.econbiz.de/10013062809
To overcome the problem of insufficient research and development (Ramp;D) on vaccines for diseases concentrated in low-income countries, sponsors could commit to purchase viable vaccines if and when they are developed. One or more sponsors would commit to a minimum price that would be paid per...
Persistent link: https://www.econbiz.de/10012751417
Antibiotic resistance constitutes a major health threat. Predicting bacterial causes of infections is key to reducing antibiotic misuse, a leading driver of antibiotic resistance. We train a machine learning algorithm on administrative and microbiological laboratory data from Denmark to predict...
Persistent link: https://www.econbiz.de/10012001911
Improving physicians’ prescription practices is a primary strategy for countering the rise in resistance to antibiotics. This would prevent physicians from incorrectly prescribing antibiotics, one of the main causes of antibiotic resistance. The increasing availability of medical data and...
Persistent link: https://www.econbiz.de/10012007715